Skip to main content
SpringerLink
Log in

Activation of CD74 inhibits migration of human mesenchymal stem cells

  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Abstract

Therapeutic administration of mesenchymal stem cells (MSCs) by systemic delivery utilizes the innate ability of the cells to home to damaged tissues, but it can be an inefficient process due to a limited knowledge of cellular cues that regulate migration and homing. Our lab recently discovered that a potent pro-inflammatory cytokine, macrophage migration inhibitory factor (MIF), inhibits MSC migration. Because MIF may act on multiple cellular targets, an activating antibody (CD74Ab) was employed in this study to examine the effect of one MIF receptor, CD74 (major histocompatibility complex class II-associated invariant chain), on MSC motility. CD74 activation inhibits in a dose-dependent manner up to 90% of in vitro migration of MSCs at 40 μg/ml CD74Ab (p < 0.001), with consistent effects observed among three MSC donor preparations. A blocking peptide from the C-terminus of CD74 eliminates the effect of CD74Ab on MSCs. This suggests that MIF may act on MSCs, at least in part, through CD74. Late-passage MSCs exhibit less chemokinesis than those at passage 2. However, MSCs remain responsive to CD74 activation during ex vivo expansion: MSC migration is inhibited ∼2-fold in the presence of 5 µg/ml CD74Ab at passage 9 vs. ∼3-fold at passage 2 (p < 0.001). Consistent with this result, there were no significant differences in CD74 expression at all tested passages or after CD74Ab exposure. Targeting CD74 to regulate migration and homing potentially may be a useful strategy to improve the efficacy of a variety of MSC therapies, including those that require ex vivo expansion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.

Similar content being viewed by others

References

  • Barbash I. M.; Chouraqui P.; Baron J.; Feinberg M. S.; Etzion S.; Tessone A.; Miller L.; Guetta E.; Zipori D.; Kedes L. H.; Kloner R. A.; Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863–868; 2003.

    Article  PubMed  Google Scholar 

  • Barrilleaux B.; Phinney D. G.; Prockop D. J.; O’Connor K. C. Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12: 3007–3019; 2006.

    Article  CAS  PubMed  Google Scholar 

  • Barrilleaux B. L.; Phinney D. G.; Fischer-Valuck B. W.; Russell K. C.; Wang G.; Prockop D. J.; O’Connor K. C. Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cells. Tissue Eng Part A 15: 2335–2346; 2009.

    Article  CAS  PubMed  Google Scholar 

  • Binsky I.; Haran M.; Starlets D.; Gore Y.; Lantner F.; Harpaz N.; Leng L.; Goldenberg D. M.; Shvidel L.; Berrebi A.; Bucala R.; Shachar I. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci U S A 104: 13408–13413; 2007.

    Article  CAS  PubMed  Google Scholar 

  • Bonab M. M.; Alimoghaddam K.; Talebian F.; Ghaffari S. H.; Ghavamzadeh A.; Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 14; 2006.

    Article  PubMed  CAS  Google Scholar 

  • Briquet A.; Dubois S.; Bekaert S.; Dolhet M.; Beguin Y.; Gothot A. Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica 95: 47–56; 2010. doi:10.3324/haematol.2009.008524.

    Article  PubMed  Google Scholar 

  • Calandra T.; Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791–800; 2003.

    Article  CAS  PubMed  Google Scholar 

  • Chan J. L.; Tang K. C.; Patel A. P.; Bonilla L. M.; Pierobon N.; Ponzio N. M.; Rameshwar P. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107: 4817–4824; 2006.

    Article  CAS  PubMed  Google Scholar 

  • Faure-Andre G.; Vargas P.; Yuseff M. I.; Heuze M.; Diaz J.; Lankar D.; Steri V.; Manry J.; Hugues S.; Vascotto F.; Boulanger J.; Raposo G.; Bono M. R.; Rosemblatt M.; Piel M.; Lennon-Dumenil A. M. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 322: 1705–1710; 2008.

    Article  CAS  PubMed  Google Scholar 

  • Fischer-Valuck B. W.; Barrilleaux B. L.; Phinney D. G.; Russell K. C.; Prockop D. J.; O’Connor K. C. Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency. Biotechnol Lett 32: 19–27; 2010. doi:10.1007/s10529-009-0110-6.

    Article  CAS  PubMed  Google Scholar 

  • Fox J. M.; Chamberlain G.; Ashton B. A.; Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137: 491–502; 2007.

    Article  CAS  PubMed  Google Scholar 

  • Herrera M. B.; Bussolati B.; Bruno S.; Morando L.; Mauriello-Romanazzi G.; Sanavio F.; Stamenkovic I.; Biancone L.; Camussi G. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72: 430–441; 2007.

    Article  CAS  PubMed  Google Scholar 

  • Ishii M.; Koike C.; Igarashi A.; Yamanaka K.; Pan H.; Higashi Y.; Kawaguchi H.; Sugiyama M.; Kamata N.; Iwata T.; Matsubara T.; Nakamura K.; Kurihara H.; Tsuji K.; Kato Y. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun 332: 297–303; 2005.

    Article  CAS  PubMed  Google Scholar 

  • Kasper G.; Mao L.; Geissler S.; Draycheva A.; Trippens J.; Kuhnisch J.; Tschirschmann M.; Kaspar K.; Perka C.; Duda G. N.; Klose J. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27: 1288–1297; 2009.

    Article  CAS  PubMed  Google Scholar 

  • Kyriakou C.; Rabin N.; Pizzey A.; Nathwani A.; Yong K. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93: 1457–1465; 2008.

    Article  CAS  PubMed  Google Scholar 

  • Leng L.; Metz C. N.; Fang Y.; Xu J.; Donnelly S.; Baugh J.; Delohery T.; Chen Y.; Mitchell R. A.; Bucala R. MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467–1476; 2003.

    Article  CAS  PubMed  Google Scholar 

  • Matuskova M.; Hlubinova K.; Pastorakova A.; Hunakova L.; Altanerova V.; Altaner C.; Kucerova L. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 2010. doi:10.1016/j.canlet.2009.08.028

  • Onodera S.; Sasaki S.; Ohshima S.; Amizuka N.; Li M.; Udagawa N.; Irie K.; Nishihira J.; Koyama Y.; Shiraishi A.; Tohyama H.; Yasuda K. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis. J Bone Miner Res 21: 876–885; 2006.

    Article  CAS  PubMed  Google Scholar 

  • Ortiz L. A.; Gambelli F.; McBride C.; Gaupp D.; Baddoo M.; Kaminski N.; Phinney D. G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100: 8407–8411; 2003.

    Article  CAS  PubMed  Google Scholar 

  • Pierre P.; Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93: 1135–1145; 1998.

    Article  CAS  PubMed  Google Scholar 

  • Santos L. L.; Dacumos A.; Yamana J.; Sharma L.; Morand E. F. Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin Exp Immunol 152: 372–380; 2008.

    Article  CAS  PubMed  Google Scholar 

  • Schenk S.; Mal N.; Finan A.; Zhang M.; Kiedrowski M.; Popovic Z.; McCarthy P. M.; Penn M. S. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25: 245–251; 2007.

    Article  CAS  PubMed  Google Scholar 

  • Sekiya I.; Larson B. L.; Smith J. R.; Pochampally R.; Cui J. G.; Prockop D. J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530–541; 2002.

    Article  PubMed  Google Scholar 

  • Starlets D.; Gore Y.; Binsky I.; Haran M.; Harpaz N.; Shvidel L.; Becker-Herman S.; Berrebi A.; Shachar I. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107: 4807–4816; 2006.

    Article  CAS  PubMed  Google Scholar 

  • Stein R.; Qu Z.; Cardillo T. M.; Chen S.; Rosario A.; Horak I. D.; Hansen H. J.; Goldenberg D. M. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood 104: 3705–3711; 2004.

    Article  CAS  PubMed  Google Scholar 

  • Tanino Y.; Makita H.; Miyamoto K.; Betsuyaku T.; Ohtsuka Y.; Nishihira J.; Nishimura M. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 283: L156–L162; 2002.

    CAS  PubMed  Google Scholar 

  • Zhang J.; Gong J. F.; Zhang W.; Zhu W. M.; Li J. S. Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 15: 585–594; 2008.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the National Science Foundation (BES-0514242). Prof. Kim O’Connor is a member of the Tulane Center for Gene Therapy. We thank Andrew Katz for his technical assistance.

Author information

Author notes

  1. Bonnie L. Barrilleaux

    Present address: Institute of Pediatric Regenerative Medicine, Shriners Hospital for Children, Sacramento, CA, 95817, USA

  2. Benjamin W. Fischer-Valuck

    Present address: School of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, 71130, USA

Authors and Affiliations

  1. Department of Chemical and Biomolecular Engineering, Tulane University, Lindy Boggs Center Room 300, New Orleans, LA, 70118, USA

    Bonnie L. Barrilleaux, Benjamin W. Fischer-Valuck, Jennifer K. Gilliam & Kim C. O’Connor

  2. Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, 33458, USA

    Donald G. Phinney

Authors
  1. Bonnie L. Barrilleaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin W. Fischer-Valuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer K. Gilliam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donald G. Phinney
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kim C. O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim C. O’Connor.

Additional information

Editor: J. Denry Sato

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barrilleaux, B.L., Fischer-Valuck, B.W., Gilliam, J.K. et al. Activation of CD74 inhibits migration of human mesenchymal stem cells. In Vitro Cell.Dev.Biol.-Animal 46, 566–572 (2010). https://doi.org/10.1007/s11626-010-9279-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-010-9279-1

Keywords

Search

Navigation